Total Assets - Theriva Biologics Inc (F:SFY) - Alpha Spread

Theriva Biologics Inc
F:SFY

Watchlist Manager
Theriva Biologics Inc Logo
Theriva Biologics Inc
F:SFY
Watchlist
Price: 2.42 EUR Market Closed
Market Cap: 41.8m EUR
Have any thoughts about
Theriva Biologics Inc?
Write Note

Theriva Biologics Inc
Total Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Theriva Biologics Inc
Total Assets Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Assets CAGR 3Y CAGR 5Y CAGR 10Y
Theriva Biologics Inc
F:SFY
Total Assets
$48.7m
CAGR 3-Years
-15%
CAGR 5-Years
13%
CAGR 10-Years
15%
Abbvie Inc
NYSE:ABBV
Total Assets
$141.9B
CAGR 3-Years
-1%
CAGR 5-Years
20%
CAGR 10-Years
17%
Gilead Sciences Inc
NASDAQ:GILD
Total Assets
$53.6B
CAGR 3-Years
-8%
CAGR 5-Years
-3%
CAGR 10-Years
6%
Amgen Inc
NASDAQ:AMGN
Total Assets
$90.9B
CAGR 3-Years
15%
CAGR 5-Years
9%
CAGR 10-Years
3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Assets
$20.1B
CAGR 3-Years
18%
CAGR 5-Years
23%
CAGR 10-Years
25%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Assets
$36.1B
CAGR 3-Years
19%
CAGR 5-Years
22%
CAGR 10-Years
26%

See Also

What is Theriva Biologics Inc's Total Assets?
Total Assets
48.7m USD

Based on the financial report for Mar 31, 2024, Theriva Biologics Inc's Total Assets amounts to 48.7m USD.

What is Theriva Biologics Inc's Total Assets growth rate?
Total Assets CAGR 10Y
15%

Over the last year, the Total Assets growth was -28%. The average annual Total Assets growth rates for Theriva Biologics Inc have been -15% over the past three years , 13% over the past five years , and 15% over the past ten years .

Back to Top